Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Test@Work Study: Evaluation of Attitudes and Uptake Within Employee Health Checks in the Construction Industry (Test@Work)

13. september 2021 opdateret af: Holly Blake, University of Nottingham

Test@Work: Evaluation of Attitudes and Uptake Within Employee Health Checks in the Construction Industry

This project is called Test@Work. In this project the investigators will offer general health checks and tailored health advice to up to 650 employees in the construction industry at sites across the East Midlands. The investigators will assess reach and uptake, and evaluate the views and perceptions of employees, managers and the delivery team. Health checks will include Body Mass Index (BMI; weight/height), waist-to-hip ratio, blood pressure, mental health screen, sexual health consultation and an opt-in rapid screening test for human immunodeficiency virus (HIV). Employees will be provided with a resource pack with information and signposting around physical activity, diabetes risk, diet, and musculoskeletal health. A digital resource providing information and signposting about workplace health screening and HIV testing will be developed and provided to managers at the participating worksites 2 weeks before their health check event.

Employees will be offered an additional text messaging service involving receipt of a series of messages with advice around HIV and testing alongside general health information. Employees will complete post-health check exit questionnaires and an exit interview. Managers will complete a post-event evaluation questionnaire and post-event interview. Mixed-methods evaluation will include assessment of reach, uptake, and intervention implementation processes.

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

The investigators will collect evaluation data with employees and company representatives.

Employees: will complete exit-questionnaires and be invited to a brief exit interview.

The investigators will collect by anonymous questionnaire: age, gender, country of birth, ethnicity, postcode, sexual orientation, employment status (FT/PT, permanent, agency, contract worker), reasons for attending, health perceptions, prior HIV testing history, influence of work on health, perceptions of employers provision for health and wellbeing, perceptions towards HIV testing in the workplace, range of tests undertaken, views about the workplace health check and future health intentions. Personal identifiers will not be collected and questionnaire data will not be provided to employers. Those employees who agree to be interviewed after the health check will be invited to a brief independent confidential interview with the project researcher.

Company representatives: will complete brief post-event questionnaire and be invited to post-event interview

The investigators will ask about the organisational/employee profile, their perceptions of company provision for health and wellbeing, perceptions towards the usefulness of the implementation toolkit and towards HIV testing in the workplace, method of delivery and their confidence to support employees who disclose a positive test outcome, views about the workplace health check and future implementation intentions.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

456

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • employee of a company in construction or related industries
  • provides informed consent

Exclusion Criteria:

  • does not speak English

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Forebyggelse
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Health Checks
Workplace health checks - in this intervention employees can select from a range of optional health checks/tests and receive tailored health advice and a health resource pack.
Offer of a general health check including opt-in sexual health consultation and HIV testing, weight/height, Body Mass Index (BMI), blood pressure, mental health screen. Provision of tailored health advice and a resource pack with information and signposting.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Health check uptake
Tidsramme: Rolling intervention delivery and data collection over 15 months
Percentage of employees choosing to take a workplace health check from total employee population across all sites
Rolling intervention delivery and data collection over 15 months

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
reasons for attending
Tidsramme: immediately post-event
Qualitative data collected on reasons for opting in to health check
immediately post-event
perceptions of employer's provision for health and wellbeing
Tidsramme: immediately post-event
Qualitative data collected on perceptions towards employer
immediately post-event
perceptions towards HIV testing in the workplace
Tidsramme: immediately post-event
Qualitative data collected on employee views towards HIV testing at work
immediately post-event
range of tests undertaken
Tidsramme: during the health check, and qualitative data immediately post-event
which of the optional checks/tests were taken by the employee
during the health check, and qualitative data immediately post-event
Employee demographic profile
Tidsramme: At recruitment
Age, Gender, country of birth, ethnicity, postcode, sexual orientation, employment status (full-time or part-time, permanent, agency, contract worker)
At recruitment

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Hjælpsomme links

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

17. august 2019

Primær færdiggørelse (Faktiske)

30. november 2020

Studieafslutning (Faktiske)

31. maj 2021

Datoer for studieregistrering

Først indsendt

6. december 2019

Først indsendt, der opfyldte QC-kriterier

28. februar 2020

Først opslået (Faktiske)

2. marts 2020

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

20. september 2021

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

13. september 2021

Sidst verificeret

1. september 2021

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • IN-UK-276-5347 HIV DVE

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

IPD-planbeskrivelse

The investigators are not collecting individual health outcomes as part of this study. The primary aim is to assess uptake and reach of this workplace health checks initiative. Anonymised qualitative data can be available on reasonable request.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med HIV

Kliniske forsøg med Test@Work

Abonner